Concepedia

Author

Karen MacKinnon

London Health Sciences Centre

Also Known As

K. MACKINNON, K. MacKinnon, K. Mackinnon, Karen M. MacKinnon, Karen MacKinnon

12

Publications

432

Citations

8

H-Index

26

Concepts

All Affiliations

London Health Sciences CentreOttawa Hospital
KM

About

Karen MacKinnon is an author at London Health Sciences Centre specializing in medicine, hematology, and medical laboratory science.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

298

2

Public Health

1

1

24

3

Emergency Medicine

1

1

24

4

Epidemiology

1

1

24

5

Immunology

1

1

75

Karen MacKinnon

×

7

Publications

418

Citations

7

H-Index

YearCitations

Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial

Mary Wells, Maureen S. Macmillan, Gillian Raab,

Radiotherapy and Oncology

2004

179

Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin

Michael J. Kovacs, Michael Keeney, Karen MacKinnon,

Clinical & Laboratory Haematology

1999

75

A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism

Michael J. Kovacs, Karen MacKinnon, David R. Anderson,

British Journal of Haematology

2001

67

Prospective assessment of the natural history of positive D-dimer results in persons with acute venous thromboembolism (DVT or PE)

John Kuruvilla, Philip S. Wells, Bev Morrow,

Thrombosis and Haemostasis

2003

37

Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism

M.J. Kovacs, Judy Kovacs, Josdalyne Anderson,

Clinical & Laboratory Haematology

2006

24

Body Weight Does Not Predict for Anti-Xa Levels after Fixed Dose Prophylaxis with Enoxaparin After Orthopedic Surgery

M.J. Kovacs, Karin Weir, Karen MacKinnon,

Thrombosis Research

1998

20

Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients

Mark Levine, Michael Keeney, Karen MacKinnon,

Thrombosis and Haemostasis

2005

16

Page 1